Leadership in Transparency
Xogene is exclusively dedicated to clinical trial disclosure, transparency, data sharing
Our suite of light, agile online tools offer the most user-friendly and cost-effective path to managing trial transparency information and processes.
The Xogene team goes above and beyond meeting even the most challenging of deadlines. They consistently deliver excellent quality work.
Global Head of Disclosures
Top 5 Pharmaceutical Company
Xogene’s strength is in our flexibility, in-depth knowledge, and technical know-how. We structure complete or supplemental outsourcing of transparency activities, provide management consulting, and deliver technology-driven solutions to suit each sponsor’s needs.
Xogene’s focus is to support organizations whose core concern is the welfare of patients and trial participants. Our vision reflects the ethics and principles of the community in which we work.
We uphold the highest standards of open and honest communication with our clients and partners and strive for continued knowledge sharing and process improvement while respecting and protecting confidential information.
Paul Ngai, M.S.
Co-founder & Chief Executive Officer
As Co-founder and CEO, Paul leads Xogene’s strategic direction as well as provides direct oversight of the Disclosure and Outsourcing Services practice.
A veteran in the field of clinical trial registration and disclosure, Paul has been working in the life sciences area since 2006 and has over 25 years of experience in technology management.
Paul’s consulting career spanned technology and project management including clinical disclosure and management consulting within the pharmaceutical industry. He received both his bachelor and master’s degree from Stevens Institute of Technology.
Co-founder & Chief Product Officer
As a seasoned technology entrepreneur and business builder, Woo oversees products and platform services for Xogene.
Prior to Xogene, Woo co-founded Intrasphere, a technology and services provider to the biopharmaceutical industry, which was acquired by Deloitte Consulting. Woo also co-founded PharmaCM, a leading clinical disclosure platform, now acquired by TrialScope.
A former derivatives trader, Woo is also a founder of Reval, a global leader of SaaS platform for treasury and risk management with clients and employees in North America, EMEA, and the Asia Pacific.
Get in Touch.
Tell us what you're interested in: (*required)
10 Sterling Boulevard
Englewood, NJ 07631